Global HPV Genetically Engineered Vaccine Supply, Demand and Key Producers, 2023-2029
The global HPV Genetically Engineered Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global HPV Genetically Engineered Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for HPV Genetically Engineered Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HPV Genetically Engineered Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HPV Genetically Engineered Vaccine total production and demand, 2018-2029, (K Units)
Global HPV Genetically Engineered Vaccine total production value, 2018-2029, (USD Million)
Global HPV Genetically Engineered Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: HPV Genetically Engineered Vaccine domestic production, consumption, key domestic manufacturers and share
Global HPV Genetically Engineered Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global HPV Genetically Engineered Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc., GSK, Walvax Biotechnology Co.,Ltd., Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Sanofi Pasteur, Serum Institute, Shanghai Zerun Biological Technology Co., Ltd., Shanghai Bovax Biotechnology Co., Ltd. and Beijing Health Guard Biotechnology Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HPV Genetically Engineered Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HPV Genetically Engineered Vaccine Market, By Region:
1. How big is the global HPV Genetically Engineered Vaccine market?
2. What is the demand of the global HPV Genetically Engineered Vaccine market?
3. What is the year over year growth of the global HPV Genetically Engineered Vaccine market?
4. What is the production and production value of the global HPV Genetically Engineered Vaccine market?
5. Who are the key producers in the global HPV Genetically Engineered Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global HPV Genetically Engineered Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for HPV Genetically Engineered Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HPV Genetically Engineered Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HPV Genetically Engineered Vaccine total production and demand, 2018-2029, (K Units)
Global HPV Genetically Engineered Vaccine total production value, 2018-2029, (USD Million)
Global HPV Genetically Engineered Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: HPV Genetically Engineered Vaccine domestic production, consumption, key domestic manufacturers and share
Global HPV Genetically Engineered Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global HPV Genetically Engineered Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global HPV Genetically Engineered Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc., GSK, Walvax Biotechnology Co.,Ltd., Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Sanofi Pasteur, Serum Institute, Shanghai Zerun Biological Technology Co., Ltd., Shanghai Bovax Biotechnology Co., Ltd. and Beijing Health Guard Biotechnology Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HPV Genetically Engineered Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global HPV Genetically Engineered Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Bivalent HPV Vaccine
- Quadrivalent HPV Vaccine
- 9-valent HPV Vaccine
- Male
- Female
- Merck & Co., Inc.
- GSK
- Walvax Biotechnology Co.,Ltd.
- Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
- Sanofi Pasteur
- Serum Institute
- Shanghai Zerun Biological Technology Co., Ltd.
- Shanghai Bovax Biotechnology Co., Ltd.
- Beijing Health Guard Biotechnology Inc.
- Jiangsu Recbio Technology Co., Ltd.
1. How big is the global HPV Genetically Engineered Vaccine market?
2. What is the demand of the global HPV Genetically Engineered Vaccine market?
3. What is the year over year growth of the global HPV Genetically Engineered Vaccine market?
4. What is the production and production value of the global HPV Genetically Engineered Vaccine market?
5. Who are the key producers in the global HPV Genetically Engineered Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 HPV Genetically Engineered Vaccine Introduction
1.2 World HPV Genetically Engineered Vaccine Supply & Forecast
1.2.1 World HPV Genetically Engineered Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World HPV Genetically Engineered Vaccine Production (2018-2029)
1.2.3 World HPV Genetically Engineered Vaccine Pricing Trends (2018-2029)
1.3 World HPV Genetically Engineered Vaccine Production by Region (Based on Production Site)
1.3.1 World HPV Genetically Engineered Vaccine Production Value by Region (2018-2029)
1.3.2 World HPV Genetically Engineered Vaccine Production by Region (2018-2029)
1.3.3 World HPV Genetically Engineered Vaccine Average Price by Region (2018-2029)
1.3.4 North America HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.5 Europe HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.6 China HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.7 Japan HPV Genetically Engineered Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HPV Genetically Engineered Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HPV Genetically Engineered Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World HPV Genetically Engineered Vaccine Demand (2018-2029)
2.2 World HPV Genetically Engineered Vaccine Consumption by Region
2.2.1 World HPV Genetically Engineered Vaccine Consumption by Region (2018-2023)
2.2.2 World HPV Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.4 China HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.5 Europe HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.6 Japan HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.7 South Korea HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.8 ASEAN HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.9 India HPV Genetically Engineered Vaccine Consumption (2018-2029)
3 WORLD HPV GENETICALLY ENGINEERED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World HPV Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023)
3.2 World HPV Genetically Engineered Vaccine Production by Manufacturer (2018-2023)
3.3 World HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023)
3.4 HPV Genetically Engineered Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global HPV Genetically Engineered Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for HPV Genetically Engineered Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for HPV Genetically Engineered Vaccine in 2022
3.6 HPV Genetically Engineered Vaccine Market: Overall Company Footprint Analysis
3.6.1 HPV Genetically Engineered Vaccine Market: Region Footprint
3.6.2 HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
3.6.3 HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: HPV Genetically Engineered Vaccine Production Value Comparison
4.1.1 United States VS China: HPV Genetically Engineered Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: HPV Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: HPV Genetically Engineered Vaccine Production Comparison
4.2.1 United States VS China: HPV Genetically Engineered Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HPV Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: HPV Genetically Engineered Vaccine Consumption Comparison
4.3.1 United States VS China: HPV Genetically Engineered Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: HPV Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based HPV Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
4.5 China Based HPV Genetically Engineered Vaccine Manufacturers and Market Share
4.5.1 China Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
4.6 Rest of World Based HPV Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HPV Genetically Engineered Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent HPV Vaccine
5.2.2 Quadrivalent HPV Vaccine
5.2.3 9-valent HPV Vaccine
5.3 Market Segment by Type
5.3.1 World HPV Genetically Engineered Vaccine Production by Type (2018-2029)
5.3.2 World HPV Genetically Engineered Vaccine Production Value by Type (2018-2029)
5.3.3 World HPV Genetically Engineered Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HPV Genetically Engineered Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Male
6.2.2 Female
6.3 Market Segment by Application
6.3.1 World HPV Genetically Engineered Vaccine Production by Application (2018-2029)
6.3.2 World HPV Genetically Engineered Vaccine Production Value by Application (2018-2029)
6.3.3 World HPV Genetically Engineered Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Details
7.1.2 Merck & Co., Inc. Major Business
7.1.3 Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
7.1.4 Merck & Co., Inc. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc. Recent Developments/Updates
7.1.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK HPV Genetically Engineered Vaccine Product and Services
7.2.4 GSK HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Walvax Biotechnology Co.,Ltd.
7.3.1 Walvax Biotechnology Co.,Ltd. Details
7.3.2 Walvax Biotechnology Co.,Ltd. Major Business
7.3.3 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
7.3.4 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
7.3.6 Walvax Biotechnology Co.,Ltd. Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Details
7.5.2 Sanofi Pasteur Major Business
7.5.3 Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
7.5.4 Sanofi Pasteur HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur Recent Developments/Updates
7.5.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.6 Serum Institute
7.6.1 Serum Institute Details
7.6.2 Serum Institute Major Business
7.6.3 Serum Institute HPV Genetically Engineered Vaccine Product and Services
7.6.4 Serum Institute HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Serum Institute Recent Developments/Updates
7.6.6 Serum Institute Competitive Strengths & Weaknesses
7.7 Shanghai Zerun Biological Technology Co., Ltd.
7.7.1 Shanghai Zerun Biological Technology Co., Ltd. Details
7.7.2 Shanghai Zerun Biological Technology Co., Ltd. Major Business
7.7.3 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.7.4 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
7.7.6 Shanghai Zerun Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
7.8 Shanghai Bovax Biotechnology Co., Ltd.
7.8.1 Shanghai Bovax Biotechnology Co., Ltd. Details
7.8.2 Shanghai Bovax Biotechnology Co., Ltd. Major Business
7.8.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.8.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
7.8.6 Shanghai Bovax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Details
7.9.2 Beijing Health Guard Biotechnology Inc. Major Business
7.9.3 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
7.9.4 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
7.9.6 Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
7.10 Jiangsu Recbio Technology Co., Ltd.
7.10.1 Jiangsu Recbio Technology Co., Ltd. Details
7.10.2 Jiangsu Recbio Technology Co., Ltd. Major Business
7.10.3 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.10.4 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu Recbio Technology Co., Ltd. Recent Developments/Updates
7.10.6 Jiangsu Recbio Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HPV Genetically Engineered Vaccine Industry Chain
8.2 HPV Genetically Engineered Vaccine Upstream Analysis
8.2.1 HPV Genetically Engineered Vaccine Core Raw Materials
8.2.2 Main Manufacturers of HPV Genetically Engineered Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 HPV Genetically Engineered Vaccine Production Mode
8.6 HPV Genetically Engineered Vaccine Procurement Model
8.7 HPV Genetically Engineered Vaccine Industry Sales Model and Sales Channels
8.7.1 HPV Genetically Engineered Vaccine Sales Model
8.7.2 HPV Genetically Engineered Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 HPV Genetically Engineered Vaccine Introduction
1.2 World HPV Genetically Engineered Vaccine Supply & Forecast
1.2.1 World HPV Genetically Engineered Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World HPV Genetically Engineered Vaccine Production (2018-2029)
1.2.3 World HPV Genetically Engineered Vaccine Pricing Trends (2018-2029)
1.3 World HPV Genetically Engineered Vaccine Production by Region (Based on Production Site)
1.3.1 World HPV Genetically Engineered Vaccine Production Value by Region (2018-2029)
1.3.2 World HPV Genetically Engineered Vaccine Production by Region (2018-2029)
1.3.3 World HPV Genetically Engineered Vaccine Average Price by Region (2018-2029)
1.3.4 North America HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.5 Europe HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.6 China HPV Genetically Engineered Vaccine Production (2018-2029)
1.3.7 Japan HPV Genetically Engineered Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 HPV Genetically Engineered Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HPV Genetically Engineered Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World HPV Genetically Engineered Vaccine Demand (2018-2029)
2.2 World HPV Genetically Engineered Vaccine Consumption by Region
2.2.1 World HPV Genetically Engineered Vaccine Consumption by Region (2018-2023)
2.2.2 World HPV Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.4 China HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.5 Europe HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.6 Japan HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.7 South Korea HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.8 ASEAN HPV Genetically Engineered Vaccine Consumption (2018-2029)
2.9 India HPV Genetically Engineered Vaccine Consumption (2018-2029)
3 WORLD HPV GENETICALLY ENGINEERED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World HPV Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023)
3.2 World HPV Genetically Engineered Vaccine Production by Manufacturer (2018-2023)
3.3 World HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023)
3.4 HPV Genetically Engineered Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global HPV Genetically Engineered Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for HPV Genetically Engineered Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for HPV Genetically Engineered Vaccine in 2022
3.6 HPV Genetically Engineered Vaccine Market: Overall Company Footprint Analysis
3.6.1 HPV Genetically Engineered Vaccine Market: Region Footprint
3.6.2 HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
3.6.3 HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: HPV Genetically Engineered Vaccine Production Value Comparison
4.1.1 United States VS China: HPV Genetically Engineered Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: HPV Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: HPV Genetically Engineered Vaccine Production Comparison
4.2.1 United States VS China: HPV Genetically Engineered Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: HPV Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: HPV Genetically Engineered Vaccine Consumption Comparison
4.3.1 United States VS China: HPV Genetically Engineered Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: HPV Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based HPV Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
4.5 China Based HPV Genetically Engineered Vaccine Manufacturers and Market Share
4.5.1 China Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
4.6 Rest of World Based HPV Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World HPV Genetically Engineered Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent HPV Vaccine
5.2.2 Quadrivalent HPV Vaccine
5.2.3 9-valent HPV Vaccine
5.3 Market Segment by Type
5.3.1 World HPV Genetically Engineered Vaccine Production by Type (2018-2029)
5.3.2 World HPV Genetically Engineered Vaccine Production Value by Type (2018-2029)
5.3.3 World HPV Genetically Engineered Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World HPV Genetically Engineered Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Male
6.2.2 Female
6.3 Market Segment by Application
6.3.1 World HPV Genetically Engineered Vaccine Production by Application (2018-2029)
6.3.2 World HPV Genetically Engineered Vaccine Production Value by Application (2018-2029)
6.3.3 World HPV Genetically Engineered Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Details
7.1.2 Merck & Co., Inc. Major Business
7.1.3 Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
7.1.4 Merck & Co., Inc. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc. Recent Developments/Updates
7.1.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK HPV Genetically Engineered Vaccine Product and Services
7.2.4 GSK HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Walvax Biotechnology Co.,Ltd.
7.3.1 Walvax Biotechnology Co.,Ltd. Details
7.3.2 Walvax Biotechnology Co.,Ltd. Major Business
7.3.3 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
7.3.4 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
7.3.6 Walvax Biotechnology Co.,Ltd. Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Details
7.5.2 Sanofi Pasteur Major Business
7.5.3 Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
7.5.4 Sanofi Pasteur HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur Recent Developments/Updates
7.5.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.6 Serum Institute
7.6.1 Serum Institute Details
7.6.2 Serum Institute Major Business
7.6.3 Serum Institute HPV Genetically Engineered Vaccine Product and Services
7.6.4 Serum Institute HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Serum Institute Recent Developments/Updates
7.6.6 Serum Institute Competitive Strengths & Weaknesses
7.7 Shanghai Zerun Biological Technology Co., Ltd.
7.7.1 Shanghai Zerun Biological Technology Co., Ltd. Details
7.7.2 Shanghai Zerun Biological Technology Co., Ltd. Major Business
7.7.3 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.7.4 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
7.7.6 Shanghai Zerun Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
7.8 Shanghai Bovax Biotechnology Co., Ltd.
7.8.1 Shanghai Bovax Biotechnology Co., Ltd. Details
7.8.2 Shanghai Bovax Biotechnology Co., Ltd. Major Business
7.8.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.8.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
7.8.6 Shanghai Bovax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Details
7.9.2 Beijing Health Guard Biotechnology Inc. Major Business
7.9.3 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
7.9.4 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
7.9.6 Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
7.10 Jiangsu Recbio Technology Co., Ltd.
7.10.1 Jiangsu Recbio Technology Co., Ltd. Details
7.10.2 Jiangsu Recbio Technology Co., Ltd. Major Business
7.10.3 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
7.10.4 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu Recbio Technology Co., Ltd. Recent Developments/Updates
7.10.6 Jiangsu Recbio Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 HPV Genetically Engineered Vaccine Industry Chain
8.2 HPV Genetically Engineered Vaccine Upstream Analysis
8.2.1 HPV Genetically Engineered Vaccine Core Raw Materials
8.2.2 Main Manufacturers of HPV Genetically Engineered Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 HPV Genetically Engineered Vaccine Production Mode
8.6 HPV Genetically Engineered Vaccine Procurement Model
8.7 HPV Genetically Engineered Vaccine Industry Sales Model and Sales Channels
8.7.1 HPV Genetically Engineered Vaccine Sales Model
8.7.2 HPV Genetically Engineered Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World HPV Genetically Engineered Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World HPV Genetically Engineered Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World HPV Genetically Engineered Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World HPV Genetically Engineered Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World HPV Genetically Engineered Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World HPV Genetically Engineered Vaccine Production Market Share by Region (2018-2023)
Table 9. World HPV Genetically Engineered Vaccine Production Market Share by Region (2024-2029)
Table 10. World HPV Genetically Engineered Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World HPV Genetically Engineered Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. HPV Genetically Engineered Vaccine Major Market Trends
Table 13. World HPV Genetically Engineered Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World HPV Genetically Engineered Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World HPV Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World HPV Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key HPV Genetically Engineered Vaccine Producers in 2022
Table 18. World HPV Genetically Engineered Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key HPV Genetically Engineered Vaccine Producers in 2022
Table 20. World HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global HPV Genetically Engineered Vaccine Company Evaluation Quadrant
Table 22. World HPV Genetically Engineered Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and HPV Genetically Engineered Vaccine Production Site of Key Manufacturer
Table 24. HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
Table 25. HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
Table 26. HPV Genetically Engineered Vaccine Competitive Factors
Table 27. HPV Genetically Engineered Vaccine New Entrant and Capacity Expansion Plans
Table 28. HPV Genetically Engineered Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China HPV Genetically Engineered Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China HPV Genetically Engineered Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China HPV Genetically Engineered Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 37. China Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 47. World HPV Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World HPV Genetically Engineered Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World HPV Genetically Engineered Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World HPV Genetically Engineered Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World HPV Genetically Engineered Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World HPV Genetically Engineered Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World HPV Genetically Engineered Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World HPV Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World HPV Genetically Engineered Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World HPV Genetically Engineered Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World HPV Genetically Engineered Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World HPV Genetically Engineered Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World HPV Genetically Engineered Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World HPV Genetically Engineered Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc. Major Business
Table 63. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
Table 64. Merck & Co., Inc. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc. Recent Developments/Updates
Table 66. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK HPV Genetically Engineered Vaccine Product and Services
Table 70. GSK HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Walvax Biotechnology Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Walvax Biotechnology Co.,Ltd. Major Business
Table 75. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 76. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
Table 78. Walvax Biotechnology Co.,Ltd. Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur Major Business
Table 87. Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
Table 88. Sanofi Pasteur HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 91. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 92. Serum Institute Major Business
Table 93. Serum Institute HPV Genetically Engineered Vaccine Product and Services
Table 94. Serum Institute HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Serum Institute Recent Developments/Updates
Table 96. Serum Institute Competitive Strengths & Weaknesses
Table 97. Shanghai Zerun Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai Zerun Biological Technology Co., Ltd. Major Business
Table 99. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 100. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
Table 102. Shanghai Zerun Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Shanghai Bovax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Shanghai Bovax Biotechnology Co., Ltd. Major Business
Table 105. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 106. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
Table 108. Shanghai Bovax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Beijing Health Guard Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Health Guard Biotechnology Inc. Major Business
Table 111. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
Table 112. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 114. Jiangsu Recbio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 115. Jiangsu Recbio Technology Co., Ltd. Major Business
Table 116. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 117. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of HPV Genetically Engineered Vaccine Upstream (Raw Materials)
Table 119. HPV Genetically Engineered Vaccine Typical Customers
Table 120. HPV Genetically Engineered Vaccine Typical Distributors
Table 1. World HPV Genetically Engineered Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World HPV Genetically Engineered Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World HPV Genetically Engineered Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World HPV Genetically Engineered Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World HPV Genetically Engineered Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World HPV Genetically Engineered Vaccine Production Market Share by Region (2018-2023)
Table 9. World HPV Genetically Engineered Vaccine Production Market Share by Region (2024-2029)
Table 10. World HPV Genetically Engineered Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World HPV Genetically Engineered Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. HPV Genetically Engineered Vaccine Major Market Trends
Table 13. World HPV Genetically Engineered Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World HPV Genetically Engineered Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World HPV Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World HPV Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key HPV Genetically Engineered Vaccine Producers in 2022
Table 18. World HPV Genetically Engineered Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key HPV Genetically Engineered Vaccine Producers in 2022
Table 20. World HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global HPV Genetically Engineered Vaccine Company Evaluation Quadrant
Table 22. World HPV Genetically Engineered Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and HPV Genetically Engineered Vaccine Production Site of Key Manufacturer
Table 24. HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
Table 25. HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
Table 26. HPV Genetically Engineered Vaccine Competitive Factors
Table 27. HPV Genetically Engineered Vaccine New Entrant and Capacity Expansion Plans
Table 28. HPV Genetically Engineered Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China HPV Genetically Engineered Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China HPV Genetically Engineered Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China HPV Genetically Engineered Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 37. China Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based HPV Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 47. World HPV Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World HPV Genetically Engineered Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World HPV Genetically Engineered Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World HPV Genetically Engineered Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World HPV Genetically Engineered Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World HPV Genetically Engineered Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World HPV Genetically Engineered Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World HPV Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World HPV Genetically Engineered Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World HPV Genetically Engineered Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World HPV Genetically Engineered Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World HPV Genetically Engineered Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World HPV Genetically Engineered Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World HPV Genetically Engineered Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc. Major Business
Table 63. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
Table 64. Merck & Co., Inc. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc. Recent Developments/Updates
Table 66. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK HPV Genetically Engineered Vaccine Product and Services
Table 70. GSK HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Walvax Biotechnology Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Walvax Biotechnology Co.,Ltd. Major Business
Table 75. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 76. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
Table 78. Walvax Biotechnology Co.,Ltd. Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur Major Business
Table 87. Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
Table 88. Sanofi Pasteur HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 91. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 92. Serum Institute Major Business
Table 93. Serum Institute HPV Genetically Engineered Vaccine Product and Services
Table 94. Serum Institute HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Serum Institute Recent Developments/Updates
Table 96. Serum Institute Competitive Strengths & Weaknesses
Table 97. Shanghai Zerun Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai Zerun Biological Technology Co., Ltd. Major Business
Table 99. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 100. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
Table 102. Shanghai Zerun Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Shanghai Bovax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Shanghai Bovax Biotechnology Co., Ltd. Major Business
Table 105. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 106. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
Table 108. Shanghai Bovax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Beijing Health Guard Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Health Guard Biotechnology Inc. Major Business
Table 111. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
Table 112. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 114. Jiangsu Recbio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 115. Jiangsu Recbio Technology Co., Ltd. Major Business
Table 116. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
Table 117. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of HPV Genetically Engineered Vaccine Upstream (Raw Materials)
Table 119. HPV Genetically Engineered Vaccine Typical Customers
Table 120. HPV Genetically Engineered Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. HPV Genetically Engineered Vaccine Picture
Figure 2. World HPV Genetically Engineered Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HPV Genetically Engineered Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 5. World HPV Genetically Engineered Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World HPV Genetically Engineered Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 10. China HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 12. HPV Genetically Engineered Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World HPV Genetically Engineered Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of HPV Genetically Engineered Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for HPV Genetically Engineered Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for HPV Genetically Engineered Vaccine Markets in 2022
Figure 26. United States VS China: HPV Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: HPV Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HPV Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 32. World HPV Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World HPV Genetically Engineered Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent HPV Vaccine
Figure 35. Quadrivalent HPV Vaccine
Figure 36. 9-valent HPV Vaccine
Figure 37. World HPV Genetically Engineered Vaccine Production Market Share by Type (2018-2029)
Figure 38. World HPV Genetically Engineered Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World HPV Genetically Engineered Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World HPV Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World HPV Genetically Engineered Vaccine Production Value Market Share by Application in 2022
Figure 42. Male
Figure 43. Female
Figure 44. World HPV Genetically Engineered Vaccine Production Market Share by Application (2018-2029)
Figure 45. World HPV Genetically Engineered Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World HPV Genetically Engineered Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. HPV Genetically Engineered Vaccine Industry Chain
Figure 48. HPV Genetically Engineered Vaccine Procurement Model
Figure 49. HPV Genetically Engineered Vaccine Sales Model
Figure 50. HPV Genetically Engineered Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. HPV Genetically Engineered Vaccine Picture
Figure 2. World HPV Genetically Engineered Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World HPV Genetically Engineered Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 5. World HPV Genetically Engineered Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World HPV Genetically Engineered Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World HPV Genetically Engineered Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 10. China HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan HPV Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 12. HPV Genetically Engineered Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World HPV Genetically Engineered Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India HPV Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of HPV Genetically Engineered Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for HPV Genetically Engineered Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for HPV Genetically Engineered Vaccine Markets in 2022
Figure 26. United States VS China: HPV Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: HPV Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: HPV Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers HPV Genetically Engineered Vaccine Production Market Share 2022
Figure 32. World HPV Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World HPV Genetically Engineered Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent HPV Vaccine
Figure 35. Quadrivalent HPV Vaccine
Figure 36. 9-valent HPV Vaccine
Figure 37. World HPV Genetically Engineered Vaccine Production Market Share by Type (2018-2029)
Figure 38. World HPV Genetically Engineered Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World HPV Genetically Engineered Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World HPV Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World HPV Genetically Engineered Vaccine Production Value Market Share by Application in 2022
Figure 42. Male
Figure 43. Female
Figure 44. World HPV Genetically Engineered Vaccine Production Market Share by Application (2018-2029)
Figure 45. World HPV Genetically Engineered Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World HPV Genetically Engineered Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. HPV Genetically Engineered Vaccine Industry Chain
Figure 48. HPV Genetically Engineered Vaccine Procurement Model
Figure 49. HPV Genetically Engineered Vaccine Sales Model
Figure 50. HPV Genetically Engineered Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
